Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 2–2 | Cite as

Mylan's valsartan products banned from EU medicines

News item
  • 25 Downloads

Reference

  1. European Medicines Agency. Valsartan from Mylan laboratories in India can no longer be used in EU medicines due to NDEA impurity. Internet Document : [2 pages], 19 Nov 2018. Available from: URL: https://www.ema.europa.eu/en/news/valsartan-mylan-laboratories-india-can-no-longer-be-used-eu-medicines-due-ndea-impurity

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations